MTT assay data showed that overexpression of IGF2BP2 resulted in elevated viability and IC50 of GBM cells, whereas overexpression of PID1 reversed the effect caused by IGF2BP2 (Figures 7C,D). The gene discussed is IGF2BP2; the disease is glioblastoma.